Keytruda (pembrolizumab)

pCPA File Number: 21168

Negotiation Status:

Concluded with an LOI

Indication(s):

Squamous Non-Small Cell Lung Cancer

Sponsor/Manufacturer:

Merck Canada Inc.

CADTH Project Number:

PC0176-000

pCPA Engagement Letter Issued:

2020-01-22

Negotiation Process Concluded:

2020-04-15